Tobacco Center Faculty Blog

November 28, 2017

Stanton A. Glantz, PhD

We just submitted this public comment on California's proposed regulations on medical marijuana labeling and formulations.  A PDF of the comment which includes the graphic elements is available here.
 
Instructions for submitting public comments on emergency cannabis regulations: https://oal.ca.gov/commenting-on-emergency-cannabis-regulations/.
Link to CDPH Notice: https://www.cdph.ca.gov/Programs/OLS/Pages/DPH-17-010E-Emergency-Cannabis-Regulations.aspx
Link to CDPH emergency regulations:  https://www.cdph.ca.gov/Programs/OLS/CDPH%20Document%20Library/DPH-17-010E_ER_RegText_Application.pdf
 
 
Comment on Proposed Regulation:
DPH-17-010E
Cannabis Manufacturing License
November 16, 2017
 
Daniel G. Orenstein, JD, MPH
Postdoctoral Fellow
 
Candice M. Bowling, JD, MPA
Postdoctoral Fellow
 
Stanton A. Glantz, PhD

November 28, 2017

Stanton A. Glantz, PhD

We just submitted this public comment on California’s Bureau of Medical Cannabis Control’s proposed emergency regulations for legalized medical marijuana sales.   A  PDF of the comment is here.
 
Instructions for submitting public comments on emergency cannabis regulations: https://oal.ca.gov/commenting-on-emergency-cannabis-regulations/.
Link to BCC Notice: http://www.bcc.ca.gov/law_regs/bcc_emerg_rulemaking.pdf
Link to BCC emergency regulations: http://www.bcc.ca.gov/law_regs/bcc_prop_text_reg.pdf
 
 
Comment on Proposed Regulation
 
CALIFORNIA CODE OF REGULATIONS TITLE 16, DIVISION 42
BUREAU OF MEDICAL CANNABIS REGULATION

November 16, 2017
 
Candice Bowling, JD, MPA[i]
Postdoctoral Fellow
 
                                                     Daniel G. Orenstein, JD, MPH[ii]

November 28, 2017

Stanton A. Glantz, PhD

Yvette van der Eijk and I justy published “Tobacco industry attempts to frame smoking as a 'disability' under the 1990 Americans with Disabilities Act” in PLoS ONE. 
 
The abstract is a nice English-language summary of how the tobacco companies tried to walk the tightrope of getting smokers declared a protected class without admitting that nicotine was addictive.  When they didn’t get that, they tried to “educate” employers that the law said something different than it actually said.
 
Here’s the abstract:
 

November 24, 2017

Stanton A. Glantz, PhD

Last August (2017), the journal addiction published a paper by Jean François  Etter, “Gateway effects and electronic cigarettes,”  that tried to dismiss the very strong and consistent evidence that adolescents who initiate tobacco product use with e-cigarettes are more likely to go on to smoke cigarettes, the so-called “gateway effect.”
 
Much like past tobacco industry efforts to use the Bradford Hill criterial for causal inference to dismiss the evidence linking smoking with lung cancer, Etter came up with something analogous to the industry’s old “constitutional hypothesis” that argued that smokers got lung cancer because there was some genetic factor that both increased the risk of lung cancer can made it more likely that someone would start smoking.  Figure 1 in his paper sums up his position:
 

November 22, 2017

Stanton A. Glantz, PhD

My colleagues at UCSF just submitted this public comment to FDA on Philip Morris' IQOS MRTP application.  The tracking number is 1k1-8zy0-6rfg.  A PDF version of the comment is available here.
 
 
Philip Morris’s Population Health Impact Model Based on Questionable Assumptions and Insufficient Health Impact Measures Does Not Adequately Support its MRTP Application
 
Wendy Max, PhD, Lauren Lempert, JD, Hai-Yen Sung, PhD, James Lightwood, PhD, Yingning Wang, PhD, and Tingting Yao, PhD
 
UCSF TCORS
Docket Number: FDA-2017-D-3001
November 22, 2017
 

Pages